Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.70 |
| ▸ | HPGD | P15428 | 3/20 | 0.70 |
| ▸ | GLA | P06280 | 2/20 | 0.70 |
| ▸ | MAPT | P10636 | 2/20 | 0.70 |
| ▸ | ACHE | P22303 | 1/20 | 0.70 |
| ▸ | HTR3A | P46098 | 1/20 | 0.56 |
| ▸ | NCF1 | P14598 | 3/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | NOS2 | P35228 | 1/20 | 0.46 |
| ▸ | BACE1 | P56817 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | NQO2 | P16083 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | STAT3 | P40763 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30141893 | 0.86 | ALDH1A1 (0.58) | ALDH1A1HPGDGLAMAPTACHE | |
| SCHEMBL732208 | 0.86 | ALDH1A1 (0.58) | ALDH1A1HPGDGLAMAPTACHE | |
| SCHEMBL12446825 | 0.85 | ALDH1A1 (0.52) | ALDH1A1HPGDGLAMAPTACHE | |
| SCHEMBL12446467 | 0.85 | CYP1A2 (0.61) | ALDH1A1HPGDGLAMAPTACHE | |
| SCHEMBL5476360 | 0.85 | CCR1 (0.61) | ALDH1A1HPGDGLAMAPTACHE | |
| Hydrochloric Acid SCHEMBL8321996 | 0.84 | ALDH1A1 (0.56) | ALDH1A1HPGDGLAMAPTACHE | |
| SCHEMBL18631801 | 0.84 | ALDH1A1 (0.56) | ALDH1A1HPGDGLAMAPTACHE | |
| SCHEMBL17898421 | 0.84 | ALDH1A1 (0.55) | ALDH1A1HPGDGLAMAPTACHE | |
| Acridine SCHEMBL1772714 | 0.83 | ALDH1A1 (1.00) | ALDH1A1HPGDGLAMAPTACHE | |
| Acridine SCHEMBL29352289 | 0.83 | ALDH1A1 (1.00) | ALDH1A1HPGDGLAMAPTACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11884685-B2 | Rhenium complexes and methods of use for treating cancer | CORNELL UNIVERSITY (US) | 2024-01-30 | — | — | US | disclosed |
| US-20230284527-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LT MATERIALS CO., LTD. (KR) | 2023-09-07 | — | — | US | disclosed |
| US-20230284527-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LT MATERIALS CO., LTD. (KR) | 2023-09-07 | — | — | US | disclosed |
| US-20220220617-A1 | TIN PLATING BATH AND A METHOD FOR DEPOSITING TIN OR TIN ALLOY ONTO A SURFACE OF A SUBSTRATE | ATOTECH DEUTSCHLAND GMBH (DE) | 2022-07-14 | — | — | US | disclosed |
| US-20210317151-A1 | RHENIUM COMPLEXES AND METHODS OF USE FOR TREATING CANCER | UNITED STATES GOVERNMENT | 2021-10-14 | — | — | US | disclosed |
| US-10973849-B2 | Rhenium complexes and methods of use for treating cancer | CORNELL UNIVERSITY (US) | 2021-04-13 | — | — | US | disclosed |
| EP-3770298-A1 | TIN PLATING BATH AND A METHOD FOR DEPOSITING TIN OR TIN ALLOY ONTO A SURFACE OF A SUBSTRATE | ATOTECH Deutschland GmbH (DE) | 2021-01-27 | — | — | EP | disclosed |
| US-20190175645-A1 | RHENIUM COMPLEXES AND METHODS OF USE FOR TREATING CANCER | CORNELL UNIVERSITY (US) | 2019-06-13 | — | — | US | disclosed |
| US-10038150-B2 | Metal complexes for use as dopants and other uses | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) | 2018-07-31 | — | — | US | disclosed |
| US-10038150-B2 | Metal complexes for use as dopants and other uses | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) | 2018-07-31 | — | — | US | disclosed |
| WO-2017223428-A1 | RHENIUM COMPLEXES AND METHODS OF USE FOR TREATING CANCER | CORNELL UNIVERSITY (US) | 2017-12-28 | — | — | WO | disclosed |
| US-20160233439-A1 | METAL COMPLEXES FOR USE AS DOPANTS AND OTHER USES | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) EPFL-TTO (CH) | 2016-08-11 | — | — | US | disclosed |
| US-20160233439-A1 | METAL COMPLEXES FOR USE AS DOPANTS AND OTHER USES | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) EPFL-TTO (CH) | 2016-08-11 | — | — | US | disclosed |
| US-20080306315-A1 | Metal-Organic Framework Catalysts and Their Use in Hydrocarbon Transformation | UNIVERSITETET I OSLO (NO) | 2008-12-11 | — | — | US | disclosed |
| EP-1909958-A2 | METAL-ORGANIC FRAMEWORK CATALYSTS AND THEIR USE IN HYDROCARBON TRANSFORMATION | Universitetet I Oslo (NO) | 2008-04-16 | — | — | EP | disclosed |
| US-7183010-B2 | Organic light-emitting diode devices with improved operational stability | EASTMAN KODAK CORPORATION (US) | 2007-02-27 | — | — | US | disclosed |
| WO-2007022307-A2 | LIGANDS FOR METAL IONS AND METHODS FOR MAKING AND USING THE SAME | UNIVERSITY OF NORTH CAROLINA AT WILMINGTON (US) | 2007-02-22 | — | — | WO | disclosed |
| WO-2007007113-A2 | METAL-ORGANIC FRAMEWORK CATALYSTS AND THEIR USE IN HYDROCARBON TRANSFORMATION | UNIVERSITETET I OSLO (NO) | 2007-01-18 | — | — | WO | disclosed |
| US-20040076853-A1 | Organic light-emitting diode devices with improved operational stability | EASTMAN KODAK COMPANY | 2004-04-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080306315-A1 | Metal-Organic Framework Catalysts and Their Use in Hydrocarbon Transformation | POF1B, PMS2, IDH1 | ALDH1A1 1365/4885HPGD 543/4885GLA 3470/4885 |
| US-10038150-B2 | Metal complexes for use as dopants and other uses | SOD1, DDT, SOD3 | ALDH1A1 3311/4885HPGD 758/4885GLA 3364/4885 |
| US-20190175645-A1 | RHENIUM COMPLEXES AND METHODS OF USE FOR TREATING CANCER | PHOSPHO1, RB1, RRM2 | ALDH1A1 4682/4885HPGD 2857/4885GLA 2974/4885 |
| US-10973849-B2 | Rhenium complexes and methods of use for treating cancer | PHOSPHO1, RB1, RRM2 | ALDH1A1 4682/4885HPGD 2857/4885GLA 2974/4885 |
| US-20160233439-A1 | METAL COMPLEXES FOR USE AS DOPANTS AND OTHER USES | SOD1, DDT, SOD3 | ALDH1A1 3311/4885HPGD 758/4885GLA 3364/4885 |
| US-20210317151-A1 | RHENIUM COMPLEXES AND METHODS OF USE FOR TREATING CANCER | ERLIN1, EGFR, ESRRG | ALDH1A1 3844/4885HPGD 3213/4885GLA 4135/4885 |
| US-11884685-B2 | Rhenium complexes and methods of use for treating cancer | ERLIN1, EGFR, ESRRG | ALDH1A1 3844/4885HPGD 3213/4885GLA 4135/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.